These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 33499905)

  • 41. Rapid Rollout and Initial Uptake of a Booster COVID-19 Vaccine Among Israel Defense Forces Soldiers.
    Talmy T; Nitzan I
    J Prev (2022); 2023 Feb; 44(1):1-14. PubMed ID: 35972594
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The changing roles of community nurses: the case of health plan nurses in Israel.
    Nissanholtz-Gannot R; Rosen B; Hirschfeld M;
    Isr J Health Policy Res; 2017 Dec; 6(1):69. PubMed ID: 29274639
    [TBL] [Abstract][Full Text] [Related]  

  • 43. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Examining national burn care policies--is the Israeli burn care alignment based on national data?
    Haik J; Weissman O; Givon A; Liran A; Tessone A; Stavrou D; Orenstein A; Peleg K;
    J Burn Care Res; 2012; 33(4):510-7. PubMed ID: 22337322
    [TBL] [Abstract][Full Text] [Related]  

  • 45. COVID-19 Incidence Proportion as a Function of Regional Testing Strategy, Vaccination Coverage, and Vaccine Type.
    Totolian AA; Smirnov VS; Krasnov AA; Ramsay ES; Dedkov VG; Popova AY
    Viruses; 2023 Oct; 15(11):. PubMed ID: 38005859
    [No Abstract]   [Full Text] [Related]  

  • 46. Quantifying inequities in COVID-19 vaccine distribution over time by social vulnerability, race and ethnicity, and location: A population-level analysis in St. Louis and Kansas City, Missouri.
    Mody A; Bradley C; Redkar S; Fox B; Eshun-Wilson I; Hlatshwayo MG; Trolard A; Tram KH; Filiatreau LM; Thomas F; Haslam M; Turabelidze G; Sanders-Thompson V; Powderly WG; Geng EH
    PLoS Med; 2022 Aug; 19(8):e1004048. PubMed ID: 36026527
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vaccination and non-pharmaceutical interventions for COVID-19: a mathematical modelling study.
    Moore S; Hill EM; Tildesley MJ; Dyson L; Keeling MJ
    Lancet Infect Dis; 2021 Jun; 21(6):793-802. PubMed ID: 33743847
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A global database of COVID-19 vaccinations.
    Mathieu E; Ritchie H; Ortiz-Ospina E; Roser M; Hasell J; Appel C; Giattino C; Rodés-Guirao L
    Nat Hum Behav; 2021 Jul; 5(7):947-953. PubMed ID: 33972767
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Coping with the COVID-19 pandemic - the role of leadership in the Arab ethnic minority in Israel.
    Saban M; Myers V; Wilf-Miron R
    Int J Equity Health; 2020 Sep; 19(1):154. PubMed ID: 32907581
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Technical guidelines for seasonal influenza vaccination in China (2022-2023)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) on Influenza Vaccination
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Oct; 56(10):1356-1386. PubMed ID: 36274602
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Israel.
    United States. Department of State. Bureau of Public Affairs
    Backgr Notes Ser; 1984 Oct; ():1-8. PubMed ID: 12178094
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Individual preferences for COVID-19 vaccination in China.
    Leng A; Maitland E; Wang S; Nicholas S; Liu R; Wang J
    Vaccine; 2021 Jan; 39(2):247-254. PubMed ID: 33328140
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pfizer-BioNTech vaccine effectiveness against Sars-Cov-2 infection: Findings from a large observational study in Israel.
    Saciuk Y; Kertes J; Mandel M; Hemo B; Shamir Stein N; Ekka Zohar A
    Prev Med; 2022 Feb; 155():106947. PubMed ID: 34974072
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Actionable lessons for the US COVID vaccine program.
    Freed GL
    Isr J Health Policy Res; 2021 Feb; 10(1):14. PubMed ID: 33608052
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The National Immunization Technical Advisory Group in Israel.
    Stein-Zamir C; Rishpon S
    Isr J Health Policy Res; 2021 Jan; 10(1):7. PubMed ID: 33499907
    [TBL] [Abstract][Full Text] [Related]  

  • 57. COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2·57 million people in Scotland (EAVE II): a prospective cohort study.
    Agrawal U; Katikireddi SV; McCowan C; Mulholland RH; Azcoaga-Lorenzo A; Amele S; Fagbamigbe AF; Vasileiou E; Grange Z; Shi T; Kerr S; Moore E; Murray JLK; Shah SA; Ritchie L; O'Reilly D; Stock SJ; Beggs J; Chuter A; Torabi F; Akbari A; Bedston S; McMenamin J; Wood R; Tang RSM; de Lusignan S; Hobbs FDR; Woolhouse M; Simpson CR; Robertson C; Sheikh A
    Lancet Respir Med; 2021 Dec; 9(12):1439-1449. PubMed ID: 34599903
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tracking Public Attitudes Toward COVID-19 Vaccination on Tweets in Canada: Using Aspect-Based Sentiment Analysis.
    Jang H; Rempel E; Roe I; Adu P; Carenini G; Janjua NZ
    J Med Internet Res; 2022 Mar; 24(3):e35016. PubMed ID: 35275835
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reporting of Allergic Reactions During Pfizer-BioNTech BNTT162B2 Vaccination in Israel.
    Anis E; Preis SA; Cedar N; Tal Y; Hershkowitz I; Hershko AY
    J Allergy Clin Immunol Pract; 2022 Nov; 10(11):2969-2976. PubMed ID: 35872216
    [TBL] [Abstract][Full Text] [Related]  

  • 60. COVID-19 vaccine hesitancy among Israeli adults before and after vaccines' availability: A cross-sectional national survey.
    Frankenthal D; Zatlawi M; Karni-Efrati Z; Keinan-Boker L; Luxenburg O; Bromberg M
    Vaccine; 2022 Oct; 40(43):6271-6276. PubMed ID: 36137905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.